CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

/PRNewswire/ -- CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed...

Related Keywords

Singapore ,Houston ,Texas ,United States ,Venkata Lokesh Battula ,Crocker Coulson ,National University ,Drug Administration ,Agency For Science ,Cytomed Therapeutics ,Md Anderson Cancer Center ,Prnewswire Cytomed Therapeutics Limited Nasdaq ,Singapore Health Science Authority ,Med Therapeutics Limited ,Cancer Center ,Investigational New Drug Application ,Health Science Authority ,Chief Operating Officer ,Private Securities Litigation Reform Act ,